AI Consulting in Bethesda

Yes, and this is a frequent request from Bethesda-area healthcare-IT firms and clinical research organizations. Every build touching protected health information starts with a Business Associate Agreement before any system access is scoped. We route PHI workloads through model endpoints with contractual zero-retention and no-training terms — the enterprise tiers from Anthropic or Azure OpenAI — and we keep data processing within HIPAA-compliant infrastructure. For clinical research environments specifically, we map data flows to the minimum necessary standard: the build accesses only the fields the workflow requires, with no broad database reads. If the research environment sits on a DoD-adjacent network with additional access constraints, we scope the integration layer accordingly and document every data path for your compliance officer and IRB coordinator to review before go-live.

Several Bethesda-area clients manage federal grant portfolios where eRA Commons is the system of record for submissions, progress reports, and personnel data. We build automation around the edges of eRA Commons — not inside it, since NIH does not provide a third-party API for direct programmatic submission. That means we focus on the workflows that feed into and out of Commons: organizing effort-reporting data from payroll systems into the format your grants manager needs to populate RPPRs, pulling budget-period expenditure figures from your financial system and flagging variances against the approved budget before the program officer asks, drafting non-competing continuation narratives from structured data the PI provides. The build doesn't replace the grants manager; it removes the assembly work so the grants manager can spend their time on the judgment calls Commons actually requires.

Corporate security reviews at large hospitality and franchise companies typically ask for architecture documentation, data flow diagrams, credential management practices, and vendor security posture — sometimes a SOC 2 summary or a completed security questionnaire. We prepare that documentation as a standard deliverable for engagements in this environment. On the technical side, our builds use scoped service accounts with least-privilege access, API credentials stored in secrets management rather than application code, and no persistent storage of customer or corporate data beyond what the workflow requires. We can participate in a vendor review call with your IT security team and answer questions directly. If the engagement requires the build to sit inside your corporate network or connect to internal systems via VPN or private endpoints rather than public APIs, we scope the integration architecture accordingly before the first line of code is written.

Fiduciary environments have two concerns that show up in every conversation: what the AI can say to clients or in client-facing documents, and what records need to be retained under SEC or FINRA rules. On the first: we don't build systems that generate unsupervised client-facing investment communications. Any output that touches a client relationship — draft emails, meeting summaries, portfolio commentary — routes through a human review step before it goes out. The AI produces a working draft; an advisor or compliance officer approves and sends. On recordkeeping: we build audit trails into workflows that touch client data, logging inputs, outputs, and the human approvals at each step in a format your compliance team can export for exam preparation. If your firm uses a specific compliance-approved communication archiving system, we integrate the workflow output with that system rather than creating a parallel record outside your existing retention infrastructure.

This is a common profile in the Bethesda corridor — a team of five to fifteen people, one or two active Phase II awards, a Series A either closed or in process, and a back office that's held together by one overextended operations person and a lot of spreadsheets. The $99 AI readiness audit is usually the right starting point because it surfaces which workflow is actually costing the most time before anyone has to commit to a build. Pre-revenue biotechs tend to have two or three high-leverage candidates: grant documentation and progress reporting, regulatory submission support, or internal knowledge management when the scientific staff turns over. We scope builds to match what an early-stage company can actually absorb — one workflow, done right, that the ops person can manage without a dedicated IT team — rather than a system that requires ongoing technical overhead the company doesn't have headcount for yet.